Loncar Investments

Loncar Investments is an investment management and index provider focused on the biotechnology and healthcare sectors. The company is best known for developing the Loncar Cancer Immunotherapy Index (LCINDX), which tracks companies developing therapies that harness the body's immune system to fight cancer. It also maintains the Loncar China BioPharma Index (LCHINA), providing exposure to the growing pharmaceutical market in China. These indices serve as the underlying benchmarks for exchange-traded funds (ETFs), such as the Loncar Cancer Immunotherapy ETF (CNCR). Founded by industry analyst Brad Loncar, the firm provides specialized investment products and insights to help investors gain exposure to innovative areas of the life sciences industry.